Trial Outcomes & Findings for Determining the Effect of an "Alternate Recovery Protocol" Versus Current Standard of Care After Cesarean Section (NCT NCT03330119)
NCT ID: NCT03330119
Last Updated: 2021-03-02
Results Overview
total narcotic utilization measured with Morphine Milligram Equivalent (MME) The conversion scale being used will be the Center for Disease Control and Prevention Morphine Equivalent Score. Lower scores represent less opioid use and a better outcome. Higher scores represent more opioid use and a worse outcome.
TERMINATED
PHASE3
1494 participants
From time of consent until hospital discharge (3 days)
2021-03-02
Participant Flow
Participant milestones
| Measure |
Alternate Management
Alternate Management: With the alternate management protocol, the pre-operative order set is the same, with the addition of a single preoperative dose of acetaminophen 1 g IV x1, gabapentin 600 mg PO x1, and ondansetron 8 mg IV x1. Post-operatively, patients receive the same ketorolac 30mg x 9 doses every 6 hours, as well as acetaminophen 975 mg every 6 hours, both given standing. These two are timed so the patient is receiving one of the two medications every 3 hours during their inpatient stay. After 9 doses of ketorolac, the patient receives 600mg of ibuprofen PO, also given standing, instead of the ketorolac. If the patient requires narcotics, they may receive them on an as needed basis. IV fluids are running at 80 cc/ hour. Patients are encouraged to ambulate, including the evening of the surgery, have their foley catheter removed 12 hours post-operatively, and can have a regular diet immediately.
|
Control
The regular Lankenau cesarean section order set.
Control: The regular Lankenau cesarean section order set includes routine vital signs, labs, IV fluids, and fetal heart monitoring. Post standard cesarean section orders include IV fluids running at 125 cc/ hour, along with routine post-partum care. In terms of pain control, most patients receive 9 doses of 30mg of IV ketorolac every 6 hours, along with hydromorphone, oxycodone/acetaminophen, or a hydromorphone PCA, per patient or attending request.
|
|---|---|---|
|
Overall Study
STARTED
|
641
|
853
|
|
Overall Study
COMPLETED
|
475
|
571
|
|
Overall Study
NOT COMPLETED
|
166
|
282
|
Reasons for withdrawal
| Measure |
Alternate Management
Alternate Management: With the alternate management protocol, the pre-operative order set is the same, with the addition of a single preoperative dose of acetaminophen 1 g IV x1, gabapentin 600 mg PO x1, and ondansetron 8 mg IV x1. Post-operatively, patients receive the same ketorolac 30mg x 9 doses every 6 hours, as well as acetaminophen 975 mg every 6 hours, both given standing. These two are timed so the patient is receiving one of the two medications every 3 hours during their inpatient stay. After 9 doses of ketorolac, the patient receives 600mg of ibuprofen PO, also given standing, instead of the ketorolac. If the patient requires narcotics, they may receive them on an as needed basis. IV fluids are running at 80 cc/ hour. Patients are encouraged to ambulate, including the evening of the surgery, have their foley catheter removed 12 hours post-operatively, and can have a regular diet immediately.
|
Control
The regular Lankenau cesarean section order set.
Control: The regular Lankenau cesarean section order set includes routine vital signs, labs, IV fluids, and fetal heart monitoring. Post standard cesarean section orders include IV fluids running at 125 cc/ hour, along with routine post-partum care. In terms of pain control, most patients receive 9 doses of 30mg of IV ketorolac every 6 hours, along with hydromorphone, oxycodone/acetaminophen, or a hydromorphone PCA, per patient or attending request.
|
|---|---|---|
|
Overall Study
Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups
|
166
|
282
|
Baseline Characteristics
Baseline Measures were only recorded and analyzed for the participants who completed the study
Baseline characteristics by cohort
| Measure |
Alternate Management
n=475 Participants
Alternate Management: With the alternate management protocol, the pre-operative order set is the same, with the addition of a single preoperative dose of acetaminophen 1 g IV x1, gabapentin 600 mg PO x1, and ondansetron 8 mg IV x1. Post-operatively, patients receive the same ketorolac 30mg x 9 doses every 6 hours, as well as acetaminophen 975 mg every 6 hours, both given standing. These two are timed so the patient is receiving one of the two medications every 3 hours during their inpatient stay. After 9 doses of ketorolac, the patient receives 600mg of ibuprofen PO, also given standing, instead of the ketorolac. If the patient requires narcotics, they may receive them on an as needed basis. IV fluids are running at 80 cc/ hour. Patients are encouraged to ambulate, including the evening of the surgery, have their foley catheter removed 12 hours post-operatively, and can have a regular diet immediately.
|
Control
n=571 Participants
The regular Lankenau cesarean section order set.
Control: The regular Lankenau cesarean section order set includes routine vital signs, labs, IV fluids, and fetal heart monitoring. Post standard cesarean section orders include IV fluids running at 125 cc/ hour, along with routine post-partum care. In terms of pain control, most patients receive 9 doses of 30mg of IV ketorolac every 6 hours, along with hydromorphone, oxycodone/acetaminophen, or a hydromorphone PCA, per patient or attending request.
|
Total
n=1046 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
475 Participants
n=99 Participants
|
571 Participants
n=107 Participants
|
1046 Participants
n=206 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Age, Continuous
|
32.4 years
STANDARD_DEVIATION 5.0 • n=99 Participants
|
31.9 years
STANDARD_DEVIATION 4.7 • n=107 Participants
|
32.1 years
STANDARD_DEVIATION 4.9 • n=206 Participants
|
|
Sex: Female, Male
Female
|
475 Participants
n=99 Participants
|
571 Participants
n=107 Participants
|
1046 Participants
n=206 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
4 Participants
n=99 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
|
3 Participants
n=107 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
|
7 Participants
n=206 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
|
|
Race (NIH/OMB)
Asian
|
14 Participants
n=99 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
|
34 Participants
n=107 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
|
48 Participants
n=206 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=99 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
|
0 Participants
n=107 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
|
0 Participants
n=206 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
|
|
Race (NIH/OMB)
Black or African American
|
142 Participants
n=99 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
|
141 Participants
n=107 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
|
283 Participants
n=206 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
|
|
Race (NIH/OMB)
White
|
302 Participants
n=99 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
|
370 Participants
n=107 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
|
672 Participants
n=206 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
|
|
Race (NIH/OMB)
More than one race
|
3 Participants
n=99 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
|
10 Participants
n=107 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
|
13 Participants
n=206 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
10 Participants
n=99 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
|
13 Participants
n=107 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
|
23 Participants
n=206 Participants • Baseline Measures were only recorded and analyzed for the participants who completed the study
|
|
Region of Enrollment
United States
|
475 participants
n=99 Participants
|
571 participants
n=107 Participants
|
1046 participants
n=206 Participants
|
PRIMARY outcome
Timeframe: From time of consent until hospital discharge (3 days)total narcotic utilization measured with Morphine Milligram Equivalent (MME) The conversion scale being used will be the Center for Disease Control and Prevention Morphine Equivalent Score. Lower scores represent less opioid use and a better outcome. Higher scores represent more opioid use and a worse outcome.
Outcome measures
| Measure |
Alternate Management
n=476 Participants
Alternate Management: With the alternate management protocol, the pre-operative order set is the same, with the addition of a single preoperative dose of acetaminophen 1 g IV x1, gabapentin 600 mg PO x1, and ondansetron 8 mg IV x1. Post-operatively, patients receive the same ketorolac 30mg x 9 doses every 6 hours, as well as acetaminophen 975 mg every 6 hours, both given standing. These two are timed so the patient is receiving one of the two medications every 3 hours during their inpatient stay. After 9 doses of ketorolac, the patient receives 600mg of ibuprofen PO, also given standing, instead of the ketorolac. If the patient requires narcotics, they may receive them on an as needed basis. IV fluids are running at 80 cc/ hour. Patients are encouraged to ambulate, including the evening of the surgery, have their foley catheter removed 12 hours post-operatively, and can have a regular diet immediately.
|
Control
n=641 Participants
The regular Lankenau cesarean section order set.
Control: The regular Lankenau cesarean section order set includes routine vital signs, labs, IV fluids, and fetal heart monitoring. Post standard cesarean section orders include IV fluids running at 125 cc/ hour, along with routine post-partum care. In terms of pain control, most patients receive 9 doses of 30mg of IV ketorolac every 6 hours, along with hydromorphone, oxycodone/acetaminophen, or a hydromorphone PCA, per patient or attending request.
|
|---|---|---|
|
Narcotic Utilization
|
33.3 MME
Standard Deviation 52.4
|
47.2 MME
Standard Deviation 60.4
|
Adverse Events
Alternate Management
Control
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place